179 related articles for article (PubMed ID: 23784898)
1. Cardiometabolic risks during anabolic hormone supplementation in older men.
He J; Bhasin S; Binder EF; Yarasheski KE; Castaneda-Sceppa C; Schroeder ET; Roubenoff R; Chou CP; Azen SP; Sattler FR
Obesity (Silver Spring); 2013 May; 21(5):968-75. PubMed ID: 23784898
[TBL] [Abstract][Full Text] [Related]
2. Durability of the effects of testosterone and growth hormone supplementation in older community-dwelling men: the HORMA Trial.
Sattler FR; Bhasin S; He J; Yarasheski KE; Binder EF; Schroeder ET; Castaneda-Sceppa C; Kawakubo M; Roubenoff R; Dunn M; Hahn C; Stewart Y; Martinez C; Azen SP
Clin Endocrinol (Oxf); 2011 Jul; 75(1):103-11. PubMed ID: 21521283
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.
Blackman MR; Sorkin JD; Münzer T; Bellantoni MF; Busby-Whitehead J; Stevens TE; Jayme J; O'Connor KG; Christmas C; Tobin JD; Stewart KJ; Cottrell E; St Clair C; Pabst KM; Harman SM
JAMA; 2002 Nov; 288(18):2282-92. PubMed ID: 12425705
[TBL] [Abstract][Full Text] [Related]
4. Interrelationships of spontaneous growth hormone axis activity, body fat, and serum lipids in healthy elderly women and men.
O'Connor KG; Harman SM; Stevens TE; Jayme JJ; Bellantoni MF; Busby-Whitehead MJ; Christmas C; Münzer T; Tobin JD; Roy TA; Cottrell E; St Clair C; Pabst KM; Blackman MR
Metabolism; 1999 Nov; 48(11):1424-31. PubMed ID: 10582552
[TBL] [Abstract][Full Text] [Related]
5. The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial.
Giannoulis MG; Sonksen PH; Umpleby M; Breen L; Pentecost C; Whyte M; McMillan CV; Bradley C; Martin FC
J Clin Endocrinol Metab; 2006 Feb; 91(2):477-84. PubMed ID: 16332938
[TBL] [Abstract][Full Text] [Related]
6. Testosterone and growth hormone improve body composition and muscle performance in older men.
Sattler FR; Castaneda-Sceppa C; Binder EF; Schroeder ET; Wang Y; Bhasin S; Kawakubo M; Stewart Y; Yarasheski KE; Ulloor J; Colletti P; Roubenoff R; Azen SP
J Clin Endocrinol Metab; 2009 Jun; 94(6):1991-2001. PubMed ID: 19293261
[TBL] [Abstract][Full Text] [Related]
7. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
[TBL] [Abstract][Full Text] [Related]
8. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
Magnussen LV; Glintborg D; Hermann P; Hougaard DM; Højlund K; Andersen M
Diabetes Obes Metab; 2016 Oct; 18(10):980-9. PubMed ID: 27265844
[TBL] [Abstract][Full Text] [Related]
9. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men.
Gannagé-Yared MH; Khalife S; Semaan M; Fares F; Jambart S; Halaby G
Eur J Endocrinol; 2006 Jul; 155(1):167-76. PubMed ID: 16793964
[TBL] [Abstract][Full Text] [Related]
10. Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men.
Münzer T; Harman SM; Hees P; Shapiro E; Christmas C; Bellantoni MF; Stevens TE; O'Connor KG; Pabst KM; St Clair C; Sorkin JD; Blackman MR
J Clin Endocrinol Metab; 2001 Aug; 86(8):3604-10. PubMed ID: 11502785
[TBL] [Abstract][Full Text] [Related]
11. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
Magnussen LV
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men.
Münzer T; Harman SM; Sorkin JD; Blackman MR
J Clin Endocrinol Metab; 2009 Oct; 94(10):3833-41. PubMed ID: 19602554
[TBL] [Abstract][Full Text] [Related]
13. Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity.
Bredella MA; Gerweck AV; Lin E; Landa MG; Torriani M; Schoenfeld DA; Hemphill LC; Miller KK
J Clin Endocrinol Metab; 2013 Sep; 98(9):3864-72. PubMed ID: 23824419
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk profile in 38-year and 18-year-old men. Contribution of body fat content and regional fat distribution.
Bonora E; Targher G; Branzi P; Zenere M; Saggiani F; Zenti MG; Travia D; Tonoli M; Muggeo M; Cigolini M
Int J Obes Relat Metab Disord; 1996 Jan; 20(1):28-36. PubMed ID: 8788319
[TBL] [Abstract][Full Text] [Related]
15. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
[TBL] [Abstract][Full Text] [Related]
16. One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults.
Boguszewski CL; Meister LH; Zaninelli DC; Radominski RB
Eur J Endocrinol; 2005 Jan; 152(1):67-75. PubMed ID: 15762189
[TBL] [Abstract][Full Text] [Related]
17. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
[TBL] [Abstract][Full Text] [Related]
18. Indices of adiposity as predictors of cardiometabolic risk and inflammation in young adults.
Pourshahidi LK; Wallace JM; Mulhern MS; Horigan G; Strain JJ; McSorley EM; Magee PJ; Bonham MP; Livingstone MB
J Hum Nutr Diet; 2016 Feb; 29(1):26-37. PubMed ID: 25677964
[TBL] [Abstract][Full Text] [Related]
19. Fifteen years of GH replacement improves body composition and cardiovascular risk factors.
Elbornsson M; Götherström G; Bosæus I; Bengtsson BÅ; Johannsson G; Svensson J
Eur J Endocrinol; 2013 May; 168(5):745-53. PubMed ID: 23428613
[TBL] [Abstract][Full Text] [Related]
20. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
Allan CA; Strauss BJ; Burger HG; Forbes EA; McLachlan RI
J Clin Endocrinol Metab; 2008 Jan; 93(1):139-46. PubMed ID: 17940111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
